Medicalsystem Biotechnology Co., Ltd (SHE:300439)

Market Cap	3.55B -21.6%
Revenue (ttm)	1.54B -5.7%
Net Income	66.57M -68.2%
EPS	0.17 -68.8%
Shares Out	384.32M
PE Ratio	54.66
Forward PE	n/a
Dividend	0.03 (0.36%)
Ex-Dividend Date	Jun 11, 2026

Volume	3,312,200
Open	9.22
Previous Close	9.24
Day's Range	9.08 - 9.25
52-Week Range	7.83 - 12.20
Beta	0.31
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 29, 2026

About SHE:300439

Medicalsystem Biotechnology Co., Ltd. researches, develops, produces, and sells in vitro diagnostic products in China. It is also involved in the provision of third-party medical diagnostic services. The company offers chemiluminescence, biochemistry, integrated combination, TLA system, hematology, point-of-care testing (POCT), mass spectrometry, and blood lipid subfraction analysis. It also provides healthcare services. Medicalsystem Biotechnology Co., Ltd. was formerly known as Ningbo Medicalsystem Biotechnology Co., Ltd. and changed its name...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2003
• Employees: 1,936
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300439

Financial Performance

In 2025, SHE:300439's revenue was 1.54 billion, a decrease of -11.67% compared to the previous year's 1.74 billion. Earnings were 63.20 million, a decrease of -75.50%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 11, 2026

Data Sources Report a data error